Multi-million dollar grants announced at ECTRIMS by the International Progressive MS Alliance marks major milestone in progressive MS research
How quickly time flies. A little over a year ago, the MS Society announced the recipients of the International Progressive MS Alliance planning…
World’s brightest minds gather in London for largest MS conference
The MS Society of Canada’s research team has arrived in the vibrant city of London, England to attend the 32nd Congress of the…
MS vaccines: Thinking outside the box for new treatments
At its heart, multiple sclerosis is believed to occur when rogue immune cells attack myelin – a fatty coating that surrounds nerve cells…
Getting personal with a promising treatment approach to MS
Multiple sclerosis is a deeply personal disease. No two people experience MS in exactly the same way, and while the underlying autoimmune event…
Getting personal with a promising treatment approach to MS
Multiple sclerosis is a deeply personal disease. No two people experience MS in exactly the same way, and while the underlying autoimmune event…
Multiple Sclerosis: Is it in our genes?
Our understanding of the genetic basis of multiple sclerosis has taken off over the past few years. Admittedly, the first link between MS…
World MS Day: Celebrating research that advances independence for people affected by MS
Since 2009, people around the world have marked the last Wednesday of every May in their calendar as World Multiple Sclerosis Day. Launched…
AAN: New answers to old questions about risk factors and disease modifiers
The precise causes of multiple sclerosis continue to baffle the scientific community, although in general most researchers agree that a combination of genes…
AAN: Pediatric-onset MS – environmental and genetic risk factors
Between 2 – 5% of multiple sclerosis cases emerge before the age of 18. Research into MS in children and adolescents – referred…
AAN Day 3: Researchers answer important questions about treatment strategies for MS
The conversations taking place on the third day at AAN shifted gears from the day before, placing the focus back on multiple sclerosis…